Portal Instrument's CEO, Dr. Patrick Anquetil, shares insights on reducing healthcare waste through reusable autoinjectors in a compelling OnDrug Delivery interview, "A Sustainable Future for Self-Injection with Connected, Reusable Autoinjectors."
We are thrilled to highlight a recent interview in OnDrug Delivery (Issue 171) featuring our CEO, Dr. Patrick Anquetil. Titled "A Sustainable Future for Self-Injection with Connected, Reusable Autoinjectors," the article tackles the significant environmental challenges and extensive waste generated by single-use autoinjectors in the self-injection market. Dr. Anquetil presents a compelling case for pivoting towards reusable electromechanical autoinjectors as a more sustainable and potentially cost-effective path forward. The discussion showcases Portal Instruments' solution, PRIME Nexus – a flexible, needle-based reusable platform – and explores broader insights into reducing waste, the benefits of connected reusable devices, and why sustainable innovation should ultimately lead to lower healthcare costs. The full article can be read in OnDrug Delivery.
Portal Instruments today announced that it will further expand its partnership with Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industries, to commercialize the Prime NEXUS™ reusable, connected autoinjector platform.
June 30, 2021 - The National Transgender Discrimination Survey Report on Health and Health Care recorded at least 80% of transgender people have either taken gender-affirming hormone therapy (GAHT) or want to take GAHT at some point.¹
December 21, 2021 - In the consumer tech world, iterations happen very fast, though most inventions are not ‘one and done’ masterpieces: the Dyson cyclone vacuum cleaner made 5,127 prototypes. In the medical device world, development takes longer.
Please fill out the details below and we will get back to you shortly.